| Year |
Citation |
Score |
| 2015 |
Ye DH, Gauthier E, Cheah MJ, Benziger J, Pan M. The effect of gas diffusion layer compression on gas bypass and water slug motion in parallel gas flow channels Aiche Journal. 61: 355-367. DOI: 10.1002/Aic.14686 |
0.612 |
|
| 2014 |
Ye D, Gauthier E, Benziger JB, Pan M. Bulk and contact resistances of gas diffusion layers in proton exchange membrane fuel cells Journal of Power Sources. 256: 449-456. DOI: 10.1016/J.Jpowsour.2014.01.082 |
0.541 |
|
| 2014 |
Gauthier E, Benziger JB. Gas management and multiphase flow in direct alcohol fuel cells Electrochimica Acta. 128: 238-247. DOI: 10.1016/J.Electacta.2013.09.047 |
0.721 |
|
| 2013 |
Hellstern T, Gauthier E, Cheah MJ, Benziger JB. The role of the gas diffusion layer on slug formation in gas flow channels of fuel cells International Journal of Hydrogen Energy. 38: 15414-15427. DOI: 10.1016/J.Ijhydene.2013.09.073 |
0.612 |
|
| 2012 |
Gauthier E, Hellstern T, Kevrekidis IG, Benziger J. Drop detachment and motion on fuel cell electrode materials. Acs Applied Materials & Interfaces. 4: 761-71. PMID 22201518 DOI: 10.1021/Am201408T |
0.645 |
|
| 2012 |
Gauthier E, Duan Q, Hellstern T, Benziger J. Water flowin, through, and around the gas diffusion layer Fuel Cells. 12: 835-847. DOI: 10.1002/Fuce.201100187 |
0.698 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Brummel-Ziedins KE, Lam PH, Gissel M, Gauthier E, Schneider DJ. Depletion of systemic concentrations of coagulation factors in blood from patients with atherosclerotic vascular disease. Coronary Artery Disease. 24: 468-74. PMID 23787362 DOI: 10.1097/MCA.0b013e3283632575 |
0.049 |
|
| 2018 |
Diéras V, Rugo HS, Schnell P, Gelmon K, Cristofanilli M, Loi S, Colleoni M, Lu DR, Mori A, Gauthier E, Huang Bartlett C, Slamon DJ, Turner NC, Finn RS. Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer. Journal of the National Cancer Institute. PMID 30032196 DOI: 10.1093/jnci/djy109 |
0.025 |
|
| 2020 |
Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, Fehrenbacher L, Mina LA, Diab S, Woodward NE, Yerushalmi R, Goodwin A, Blum JL, Martin M, Quek RGW, Tudor IC, ... ... Gauthier E, et al. Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy. Jnci Cancer Spectrum. 4: pkz085. PMID 32337496 DOI: 10.1093/jncics/pkz085 |
0.025 |
|
| 2012 |
Wang-Gillam A, Arnold SM, Bukowski RM, Rothenberg ML, Cooper W, Wang KK, Gauthier E, Lockhart AC. A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors. Investigational New Drugs. 30: 266-72. PMID 20697774 DOI: 10.1007/S10637-010-9506-3 |
0.023 |
|
| 2012 |
Ray-Coquard I, Italiano A, Bompas E, le Cesne A, Robin YM, Chevreau C, Bay JO, Bousquet G, Piperno-Neumann S, Isambert N, Lemaitre L, Fournier C, Gauthier E, Collard O, Cupissol D, et al. Sorafenib for patients with advanced angiosarcoma: A phase ii trial from the french sarcoma group (GSF/GETO) Oncologist. 17: 260-266. PMID 22285963 DOI: 10.1634/theoncologist.2011-0237 |
0.022 |
|
| 2021 |
Finn RS, Rugo HS, Gelmon KA, Cristofanilli M, Colleoni M, Loi S, Schnell P, Lu DR, Theall KP, Mori A, Gauthier E, Bananis E, Turner NC, Diéras V. Long-Term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis With Up to 5 Years of Follow-Up. The Oncologist. PMID 33486783 DOI: 10.1002/onco.13684 |
0.021 |
|
| 2020 |
Hurvitz SA, Gonçalves A, Rugo HS, Lee KH, Fehrenbacher L, Mina LA, Diab S, Blum JL, Chakrabarti J, Elmeliegy M, DeAnnuntis L, Gauthier E, Czibere A, Tudor IC, Quek RGW, et al. Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial. The Oncologist. 25: e439-e450. PMID 32162822 DOI: 10.1634/theoncologist.2019-0493 |
0.015 |
|
| 2023 |
Pfeiler G, Hlauschek D, Mayer EL, Deutschmann C, Kacerovsky-Strobl S, Martin M, Meisel JL, Zdenkowski N, Loibl S, Balic M, Park H, Prat A, Isaacs C, Bajetta E, Balko JM, ... ... Gauthier E, et al. Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300126. PMID 37556775 DOI: 10.1200/JCO.23.00126 |
0.014 |
|
| 2019 |
Finn RS, Liu Y, Zhu Z, Martín M, Rugo HS, Diéras V, Im SA, Gelmon KA, Harbeck N, Lu DR, Gauthier E, Huang Bartlett C, Slamon DJ. Biomarker Analyses of Response to Cyclin Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women With Treatment-Naïve Metastatic Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31527167 DOI: 10.1158/1078-0432.Ccr-19-0751 |
0.011 |
|
| 2016 |
Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Diéras V, Slamon DJ. Palbociclib and Letrozole in Advanced Breast Cancer. The New England Journal of Medicine. 375: 1925-1936. PMID 27959613 DOI: 10.1056/Nejmoa1607303 |
0.01 |
|
| 2024 |
Mayer EL, Ren Y, Wagle N, Mahtani R, Ma C, DeMichele A, Cristofanilli M, Meisel J, Miller KD, Abdou Y, Riley EC, Qamar R, Sharma P, Reid S, Sinclair N, ... ... Gauthier E, et al. PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2301940. PMID 38513188 DOI: 10.1200/JCO.23.01940 |
0.01 |
|
| 2024 |
Slamon DJ, Diéras V, Rugo HS, Harbeck N, Im SA, Gelmon KA, Lipatov ON, Walshe JM, Martin M, Chavez-MacGregor M, Bananis E, Gauthier E, Lu DR, Kim S, Finn RS. Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300137. PMID 38252901 DOI: 10.1200/JCO.23.00137 |
0.01 |
|
| 2020 |
Finn RS, Cristofanilli M, Ettl J, Gelmon KA, Colleoni M, Giorgetti C, Gauthier E, Liu Y, Lu DR, Zhang Z, Bartlett CH, Slamon DJ, Turner NC, Rugo HS. Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials. Breast Cancer Research and Treatment. PMID 32783178 DOI: 10.1007/S10549-020-05782-4 |
0.01 |
|
| 2019 |
Rugo HS, Finn RS, Gelmon K, Joy AA, Harbeck N, Castrellon A, Mukai H, Walshe JM, Mori A, Gauthier E, Lu DR, Bananis E, Martin M, Diéras V. Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2. Clinical Breast Cancer. PMID 31836434 DOI: 10.1016/J.Clbc.2019.08.009 |
0.01 |
|
| 2019 |
Diéras V, Harbeck N, Joy AA, Gelmon K, Ettl J, Verma S, Lu DR, Gauthier E, Schnell P, Mori A, Rugo HS, Finn RS. Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial. The Oncologist. PMID 31217344 DOI: 10.1634/theoncologist.2019-0019 |
0.01 |
|
| 2019 |
Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, et al. Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. Journal of Global Oncology. 1-19. PMID 31125276 DOI: 10.1200/JGO.18.00173 |
0.01 |
|
| 2013 |
Chevreau C, Le Cesne A, Ray-Coquard I, Italiano A, Cioffi A, Isambert N, Robin YM, Fournier C, Clisant S, Chaigneau L, Bay JO, Bompas E, Gauthier E, Blay JY, Penel N. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer. 119: 2639-44. PMID 23589078 DOI: 10.1002/cncr.28109 |
0.01 |
|
| 2004 |
Snanoudj R, Durrbach A, Gauthier E, Adams D, Samuel D, Ferlicot S, Bedossa P, Prigent A, Bismuth H, Charpentier B. Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 19: 1779-85. PMID 15150345 DOI: 10.1093/ndt/gfh063 |
0.01 |
|
| Hide low-probability matches. |